A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Orifarm Group acquires pharmaceutical portfolio from Takeda for up to €615 million; Carlyle Global Credit commits strategic capital to support Orifarm's growth, transaction expected to close Q4 2024
Published:
September 14, 2024
by Contify Life Science News
|
CA AB3063: Requires pharmacies to obtain a sterile compounding license and adhere to U.S. Pharmacopeia-National Formulary standards for drug preparation.
Published:
September 13, 2024
by California 2023-2024 Session
|
Survey: 63% of rheumatic condition patients substitute cannabis for prescription drugs; respondents cite better symptom management, fewer side effects as reasons
Published:
September 12, 2024
by National Organization for the Reform of Marijuana Laws (NORML)
|
NJ A4682: Prohibits insurance carriers from denying nonopioid drug coverage in favor of opioids.
Published:
September 12, 2024
by New Jersey 2024-2025 Regular Session
|
MA H4656: Requires practitioners to discuss and document non-opioid pain treatment alternatives with patients before prescribing opioids.
Published:
September 12, 2024
by Massachusetts 193rd General Court
|
Ask us about our Health Care Sector market view